A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Recruiting

Phase 1

LY3962681A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Sponsor:

Prevail Therapeutics

Code:

NCT06565195

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Accepted

Interventions

LY3962681

Placebo (aCSF)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-25. This information was provided to ClinicalTrials.gov by Prevail Therapeutics on 2025-10-22.